The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration
Open accessAbstract
We report here that amyotrophic lateral sclerosis-linked superoxide dismutase 1 (SOD1) mutants with different biochemical characteristics disrupted the blood-spinal cord barrier in mice by reducing the levels of the tight junction proteins ZO-1, occludin and claudin-5 between endothelial cells. This resulted in microhemorrhages with release of neurotoxic hemoglobin-derived products, reductions in microcirculation and hypoperfusion. SOD1 mutant-mediated endothelial damage accumulated before motor neuron degeneration and the neurovascular inflammatory response occurred, indicating that it was a central contributor to disease initiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in SOD1 transgenic mice expressing dismutase-active (G93A and G37R) and dismutase-inactive (G85R) mutations have suggested that BSCB breakdown occurs before motor neuron injury (194, 415, 651, 687, 688).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [687]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“BBB disruption including diminished levels of TJ proteins, immunoglobulin G (IgG) and hemosiderin perivascular deposits, and GLUT1 reduction has been shown to precede neuroinflammation, motor neuron loss, and motor impairment in different types of SOD1 mutants (415, 687, 688).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [687]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For instance, SOD1 G93A mice develop ultrastructural capillary alterations, extravasation of RBCs, and deposition of fibrin(ogen) and hemosiderin deposits in the brain stem and spinal cord early in the disease (194, 651, 687).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [687]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
Self-citationALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Boillée, S., Velde, C. V., & Cleveland, D. W. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.018 · Cited by 1,476
Self-citationOosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., Dorpe, J. V., Hellings, P., Gorselink, M., Heymans, S., et al. (2001) · Nature Genetics · doi:10.1038/88842 · Cited by 1,007
Lambrechts, D., Storkebaum, E., Morimoto, M., Del‐Favero, J., Smet, F. D., Marklund, S. L., Wyns, S., Thijs, V., Andersson, J., van Marion, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1211 · Cited by 853
Neurovascular mechanisms of Alzheimer's neurodegeneration
Zlokovic, B. V. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.02.001 · Cited by 770
Pun, S., Santos, A. F., Saxena, S., Xu, L., & Caroni, P. (2006) · Nature Neuroscience · doi:10.1038/nn1653 · Cited by 689
Axonal damage markers in cerebrospinal fluid are increased in ALS
Brettschneider, J., Petzold, A., Süßmuth, S. D., Ludolph, A. C., & Tumani, H. (2006) · Neurology · doi:10.1212/01.wnl.0000203120.85850.54 · Cited by 261
Garbuzova-Davis, S. N., Saporta, S., Haller, E. M., Kolomey, I., Bennett, S. P., Potter, H., & Sanberg, P. R. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001205 · Cited by 253
Ultrastructure of blood–brain barrier and blood–spinal cord barrier in SOD1 mice modeling ALS
Garbuzova-Davis, S., Haller, E., Saporta, S., Kolomey, I., Nicosia, S. V., & Sanberg, P. R. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.044 · Cited by 239
Cited by
Sorted by citations
Items 401–476 of 476
Tsvetkova, D. D., Ivanova, S. A., & Obreshkova, D. P. (2023) · International Journal Of Pharmaceutical Research And Allied Sciences · doi:10.51847/w9frjsnxjp · Cited by 2
Dutta, R. (2020) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001035 · Cited by 3
Neuroimmunology of Amyotrophic Lateral Sclerosis
Henkel-Tigges, J., Beers, D. R., Zhao, W., & Appel, S. H. (2014) · doi:10.1002/9781118406557.ch8 · Cited by 2
A gliovascular idea for the white matter repair?
Zloković, B. V. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12174 · Cited by 2
Expressional prerequisites for targeted drug delivery to the pathological brain
Helgudóttir, S. S. (2021) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau424058297 · Cited by 1
Unveiling the neuro-vascular interplay in the skeletal muscle in health, injury and diseasePreprint
Fuertes-Álvarez, S., Ascensión, A. M., Pelaez-Poblet, N., Elicegui, A., González-Granero, S., Gomez-Sanchez, J. A., Osta, R., García‐Verdugo, J. M., Alonso‐Martín, S., & Izeta, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.12.669843 · Cited by 2
Sanghai, N., Pierce, K., Sharma, N. K., Leggett, S., Yadav, T. C., Masrori, P., Atukorallaya, D., Palaniyandi, S., Marcogliese, P. C., & Tranmer, G. K. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.71078 · Cited by 1
CNS Gene Therapy Utilizing Intravenously Administered Viral Vectors
Bevan, A. K., & Kaspar, B. K. (2013) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-1-4614-9105-7_17 · Cited by 1
The effects of wild-type and mutant SOD1 on smooth muscle contraction
Nikolić‐Kokić, A., Oreščanin-Dušić, Z., Spasojević, I., Blagojević, D. P., Stević, Z., Anđjus, P. R., & Spasić, M. B. (2014) · Archives of Biological Sciences · doi:10.2298/abs141006023n · Cited by 1
Sleep‐based therapy: A new treatment for amyotrophic lateral sclerosis
Cai, Q., Li, M., & Li, Q. (2021) · Brain Science Advances · doi:10.26599/bsa.2021.9050010 · Cited by 1
Astrocyte-Neuron Interactions Contributing to Amyotrophic Lateral Sclerosis Progression
Jensen, B. K. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-64839-7_12 · Cited by 1
Tang, J., Kang, Y., Chen, Q., Zhang, B., Shang, N., Lan, J., Wu, L., & Peng, Y. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106987 · Cited by 1
Amyotrophic Lateral Sclerosis: A Glial Perspective
Valori, C. F., Brambilla, L., & Rossi, D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0974-2_11 · Cited by 1
Nikolić‐Kokić, A., Oreščanin-Dušić, Z., Slavić, M., Spasojević, I., Stević, Z., Spasić, M. B., & Blagojević, D. P. (2013) · Journal of Medical Biochemistry · doi:10.2478/jomb-2013-0032 · Cited by 1
Genetic Factors in Environmentally Induced Disease
Greenamyre, J. T., & Barrett, P. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800228-5.00002-9 · Cited by 1
Metabolomics Studies of ALS A multivariate search for clues about a devastating disease.
Wuolikainen, A. (2009) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Blood-Brain Barrier Permeability and Inflammation in Cerebral Small Vessel Disease
Walsh, J. (2019) · Apollo (University of Cambridge) · doi:10.17863/cam.50869 · Cited by 2
Endothelial iron homeostasis regulates BBB integrity via the HIF2α – Ve-cadherin pathwayPreprint
Rand, D., Ravid, O., Atrakchi, D., Israelov, H., Bresler, Y., Shemesh, C., Omesi, L., Zaltsman, S. L., Gosselet, F., Maskrey, T. S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.28.358473 · Cited by 1
Zhu, L. J., Wang, M., Liu, Y., Zhang, W., Zhang, H., Roe, A. W., & Wang, X. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.29.470313 · Cited by 1
Wasielewska, J. M., Cabral-da-Silva, M. C., Pecoraro, M., Nguyen, T. H., Bella, V. L., Oikari, L. E., Ooi, L., & White, A. R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.22.581567 · Cited by 1
Novel Therapeutic Approaches to Malignant Gliomas
Cuddapah, V. A., & Sontheimer, H. W. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0974-2_14
Talan, J. (2009) · Neurology Today · doi:10.1097/01.nt.0000366070.75591.d0
Traces of disease in amyotrophic lateral sclerosis
Verstraete, E. (2012) · Utrecht University Repository (Utrecht University)
Wilson, M. (2011) · D-Scholarship@Pitt (University of Pittsburgh)
Antioxidants and Anti-Inflammatory Drugs in the Treatment of Motor Neuron Disease
Esmaeili, M. A., & Kiaei, M. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_132
de Oliveira, G. P. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-06062014-101803
Venturin, G. T. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Sullivan, S. M., Zloković, B. V., & Appel, H. (2013)
Alves, C. J. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2015.tde-24112015-082439
Département de Microbiologie et Immunologie
Terouz, S. (2010)
A molecular biological consideration on the transport of DHA-bound Phosphatidylcholine
Hibino, H. (2016) · Journal of Lipid Nutrition · doi:10.4010/jln.25.197
Lam, L., Halder, R. C., Montoya, D. J., Rubbi, L., Rinaldi, A. O., Sagong, B., Rubattino, R., Singh, R. R., Pellegrini, M. A., Fiala, M., et al. (2015)
Pathophysiology of the Blood–Brain Barrier in Neuroinflammatory Diseases
Majerová, P., & Kováč, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-45514-3_4
Inhibition of TDP-43 Aggregation using Native State Binding Ligands
Sun, Y. (2014) · TSpace (University of Toronto)
Post-stroke dizziness of visual-vestibular cortices origin
Inoue, N., & Goto, S. (2020) · Journal of Neuroscience and Neurological Disorders · doi:10.29328/journal.jnnd.1001038
(2013) · Wiley eBooks · doi:10.1002/9781118553480.ch11
Lipton, S. A., & Dolatabadi, N. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732909303.793555051
THEME 10IN VIVOEXPERIMENTAL MODELS
(2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.960187
Marco, R., Stefano, M., Petrillo, G., Andrea, P., Cagnotti, G., & Corona, C. (2022) · Medical Research Archives · doi:10.18103/mra.v10i9.3152
Matsuo, K., Nagata, K., Umeda, R., Shiota, T., Morimoto, S., Suzuki, N., Aoki, M., Okano, H., Nakamori, M., & Nishihara, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.15.575002
Oxisteróis e sua relação com a neuroinflamação na esclerose lateral amiotrófica
Lima, R. S. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.46.2023.tde-12122023-105206
Emerging trends in the blood spinal-cord barrier: A bibliometric analysis
Xu, B., Zhang, D., Yang, B., Chen, X., Jin, Z., Qin, X., Ma, G.-L., Sun, K., Zhu, L., Wei, X., et al. (2024) · Medicine · doi:10.1097/md.0000000000037125 · Cited by 2
Evaluation of the Relationship between Zonulin and Claudin-5 Levels and Essential TremorPreprint
Can, N. U., Ulaş, S. B., Aras, Y. G., Gözükara, S. I., Acar, T., & Acar, B. A. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4745889
Koehn, L. M., Jalaldeen, R., Pelle, J., & Nicolazzo, J. A. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114434
Antisense oligonucleotide drugs for neurological and neuromuscular diseases
Lane, R. M., & Bennett, C. F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00039-x
Theme 5 Human Cell Biology and Pathology
(2024) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2403302
Generation of a Three-dimensional Human Neurovascular Unit Model in a Microfluidic ChipPreprint
Qiu, B., Pompe, S., Xenaki, K. T., Henegouwen, P. M. P. V. B. E., Oliveira, S., Mastrobattista, E., & Caiazzo, M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.13.648605
Can, N. U., Ulaş, S. B., Aras, Y. G., Gözükara, S. I., Acar, T., Seğmen, H., & Acar, B. A. (2025) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-025-00295-2
Early endothelial activation at the blood–nerve barrier defines a hallmark of ALSPreprint
Bhat, G. P., Diprima, S., Beccaría, C. G., Podini, P., Badaloni, A., Motta, A., Brambilla, I., Martins, L. F., Boselli, D., de Pretis, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.31.673224
Negi, R., Sharma, S., & Sharma, B. (2025) · Springer eBooks · doi:10.1007/978-981-95-0125-0_11
Theme 10 Disease Stratification and Phenotyping of Patients
(2025) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2025.2564560
Magota, H., Sasaki, M., Kataoka-Sasaki, Y., Oka, S., Ukai, R., Kiyose, R., Onodera, R., Kocsis, J. D., & Honmou, O. (2021) · Figshare · doi:10.6084/m9.figshare.14559070
Waters, S., Swanson, M. E. V., Dieriks, B. V., Zhang, Y. B., Grimsey, N. L., Murray, H. C., Turner, C., Waldvogel, H., Faull, R. L. M., An, J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16456701
Xie, X., Li, M., Guan, T., Teng, Z., Feng, J., Xu, J., Qi, Q., Xiao, Y., Lv, P., & Dong, Y. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1720400
Garbuzova-Davis, S. N., Manora, L., & Borlongan, C. V. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1684694
Averchuk, E. S., Salmina, A. B., Akhmadieva, L. A., Mukhamedyarov, M. A., & Illarioshkin, S. N. (2025) · Annals of Clinical and Experimental Neurology · doi:10.17816/acen.1240 · Cited by 1
Aebischer, J. (2011) · theses.fr (ABES) · doi:10.70675/7dc30612zb4b4z49a3z864bz8fa2e995aa0e
The role of serotoninergic neurons in amyotrophic lateral sclerosis
Oussini, H. E. (2016) · theses.fr (ABES) · doi:10.70675/2431e8ddzd4e4z4710z81dcz14100daa6294
La neuroimmunité dans la sclérose latérale amyotrophique
Coque, E. (2017) · theses.fr (ABES) · doi:10.70675/30e0135azd2a1z4ee4zaeb7za9ba7cf0f4d3
Implication des macrophages périphériques dans la Sclérose latérale Amyotrophique
Chiot, A. (2018) · theses.fr (ABES) · doi:10.70675/e3d90f5az237az4722zbff2z9c99590e826b
Fan, K., Hou, Y., Gao, X., Li, J., Tang, G., Wang, Q., Yang, W., Xie, Q., Xu, R., Liu, D., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-6356438/v1
Aderinto, N., Mbah, E. C., Abioye, A. H., Kolo, R. M., Tembo, W., Arumugam, H. K., Javed, A., Akinbo, O. E., Olalusi, M. P., & Egwu, E. O. (2026) · Sclerosis · doi:10.3390/sclerosis4030018
Assialioui, A., Povedano, M., Senau, M., Ferrer, I., & Arias, L. (2026) · Biomedicines · doi:10.3390/biomedicines14071612
Martin, C., Robert, J., Bernard, S., & Girard, A. (2023) · Journal of Applied Pharmaceutical Technologies and Systems · doi:10.68159/b789825600
Viljoen, S. J., Chaves, J. C. S., Peall, I. W., White, A. R., & Oikari, L. E. (2026) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2026.126168
Xie, J., Xie, H., Li, Y., Jiang, W., Wang, X., Xie, Q., Song, X., Fan, D., Li, H., & Deng, B. (2026) · Annals of Neurology · doi:10.1002/ana.78321
Martynova, E., Mukhamedyarov, M., Kabwe, E., Khaiboullina, S. F., Simwalangana, O., Markelova, M., Rizvanov, A. A., Arkhipova, S. S., & Salafutdinov, I. I. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198604
Liao, K., Lin, J., Zhou, Y., & Lewandowski, S. A. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02449-x
Lee, H. N. R., Lin, J., Baer, B., Haffizulla, A., Ware, L. B., Harrison, F. E., & Bastarache, J. A. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.107062
The importance of the Hedgehog signaling pathway at the level of the blood-brain barrier
Dodelet-Devillers, A. (2009) · doi:10.71781/29601
Metadata
- Authors
- Zhong, Z., Deane, R., Ali, Z., Parisi, M., Shapovalov, Y., O'Banion, M. K., Stojanovic, K., Sagare, A., Boillee, S., Cleveland, D. W., & Zlokovic, B. V.
- Affiliations
- University of Rochester Medicine (US)
- Ludwig Cancer Research (BE)
- Venue
- Nature Neuroscience
- Published
- 2008-03-16
- Volume
- 11
- Issue
- 4
- Pages
- 420-422
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC2895310
- OpenAlex
- W1968758728
- Cited by
- 476
- References
- 15
- Citations by year
- 2026: 12 · 2025: 18 · 2024: 29 · 2023: 26 · 2022: 20 · 2021: 33 · 2020: 27 · 2019: 26 · 2018: 22 · 2017: 18 · 2016: 18 · 2015: 25 · 2014: 32 · 2013: 28 · 2012: 31
- FWCI
- 23.74
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R37AG023084)
- National Heart, Lung, and Blood Institute (HL63290, R01HL063290)
- National Institute of Neurological Disorders and Stroke (R37NS034467, R37 NS 27036, R37NS027036, R01NS034467, R37NS34467)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
- Keywords
- amyotrophic lateral sclerosis, mutant SOD1, blood-spinal cord barrier, tight junction proteins, ZO-1, occludin, claudin-5, endothelial injury, microhemorrhages, microcirculation, hypoperfusion, neurovascular inflammation, motor neuron degeneration, disease initiation
- MeSH terms
- Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Blood-Brain Barrier, Capillaries, Endothelium, Vascular, Hemorrhage, Humans, Isoenzymes, Membrane Proteins, Mice, Mutant Strains, Motor Neurons, Nerve Degeneration, Phosphoproteins, Spinal Cord, Superoxide Dismutase, Disease Progression, Tight Junctions, Mice, Claudin-5, Occludin, Zonula Occludens-1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
